Association of nesfatin-1 and fat mass in cystic fibrosis

Respiration

Volumn 86, Issue 4, 2013, Pages 312-317

  Cohen, Rubin I ^a   Ginsberg, Nicole ^a   Tsang, Donna ^a   Wann, Li Chen ^a   Ye, Xiaobing ^a   Liu, Shu Fang ^a  

^a Cystic Fibrosis Center   (United States)

Author keywords

Anorexia; Cystic fibrosis; Cytokines; Fat mass; Nesfatin 1

Indexed keywords

CYTOKINE; GHRELIN; HORMONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; NESFATIN 1; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; PEPTIDE HORMONE;

ADULT; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT MASS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; WEIGHT REDUCTION; AGED; HORMONE BLOOD LEVEL; MOLECULAR PATHOLOGY; SPIROMETRY;

ADIPOSITY; ADOLESCENT; ADULT; AGED; APPETITE REGULATION; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; WEIGHT LOSS; YOUNG ADULT;

EID: 84888061214     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000345375     Document Type: Article

References (24)

1. Milla CE: Nutrition and lung disease in cystic fibrosis. Clin Chest Med 2007; 28: 319-330.
2. Cohen RI, Tsang D, Koenig S, et al: Plasma ghrelin and leptin in adult cystic fibrosis patients. J Cyst Fibros 2008; 7: 398-402.
3. Cohen RI, Chandra S, Koenig S, et al: Ghrelin receptor expression in lymphocytes isolated from adult cystic fibrosis patients. Respiration 2010; 79: 141-146.
4. Oh-I S, Shimizu H, Satoh T, et al: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006; 443: 709-712.
5. Goebel-Stengel M, Wang L, Stengel A, Taché Y: Localization of nesfatin-1 neurons in the mouse brain and functional implication. Brain Res 2011; 1396: 20-34.
6. Pan W, Hsuchou H, Kastin AJ: Nesfatin-1 crosses the blood brain barrier without saturation. Peptides 2007; 28: 2223-2228.
7. Price TO, Samson WK, Niehoff ML, et al: Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides 2007; 28: 2372-2381.
8. Shimizu H, Oh-I S, Hashimoto K, et al: Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 2009; 150: 662-671.
9. Aydin S, Dag E, Ozkan Y, et al: Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol Cell Biochem 2009; 328: 49-56.
10. Saldanha JF, Carrero JJ, Mafra D: The possible role of nesfatin-1 on appetite regulation in hemodialysis patients. Med Hypotheses 2011; 77: 654-657.
11. Li QC, Wang HY, Chen X, et al: Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 2010; 159: 72-77.
12. Ogiso K, Asakawa A, Amitani H, et al: Plasma nesfatin-1 concentrations in restrictingtype anorexia nervosa. Peptides 2011; 32: 150-153.
13. Tan BK, Hallschmid M, Kern W, et al: Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment. J Clin Endocrinol Metab 2011; 96:E669-E673.
14. Stenbit AE, Flume PA: Pulmonary exacerbations in cystic fibrosis. Curr Opin Pulm Med 2011; 17: 442-447.
15. Hollander FM, De Roos NM, De Vries JH, et al: Assessment of nutritional status in adult patients with cystic fibrosis: whole-body bioimpedance vs body mass index, skinfolds, and leg-to-leg bioimpedance. J Am Diet Assoc 2005; 105: 549-555.
16. Dixit VD, Schaffer EM, Pyle RS, et al: Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004; 114: 57-66.
17. Dhillo WS: Appetite regulation. Thyroid 2007; 17: 433-445.
18. Sood A, Qualls C, Schuyler M, Thyagarajan B, Steffes MW, Smith LJ, Jacobs DR Jr: Low serum adiponectin predicts future risk for asthma in women. Am J Respir Crit Care Med 2012; 186: 41-48.
19. Chen X, Dong J, Jiang ZY: Nesfatin-1 influences the excitability of glucosensing neurons in the hypothalamic nuclei and inhibits the food intake. Regul Pept 2012; 177: 21-26.
20. Iwasaki Y, Nakabayashi H, Kakei M, Shimizu H, Mori M, Yada T: Nesfatin-1 evokes Ca 2+ signaling in isolated vagal afferent neurons via Ca 2+ influx through N-type channels. Biochem Biophys Res Commun 2009; 390: 958-962.
21. Bonnet MS, Pecchi E, Trouslard J, Jean A, Dallaporta M, Troadec JD: Central nesfatin-1-expressing neurons are sensitive to peripheral inflammatory stimulus. J Neuroinflammation 2009; 6: 27.
22. King S, Wilson J, Kotsimbos T, et al: Body composition assessment in adults with cystic fibrosis: comparison of dual-energy X-ray absorptiometry with skinfolds and bioelectrical impedance analysis. Nutrition 2005; 21: 1087-1094.
23. Yohannes AM, Willgoss TG, Fatoye FA, et al: Relationship between anxiety, depression, and quality of life in adult patients with cystic fibrosis. Respir Care 2012; 57: 550-556.
24. Stengel A, Goebel M, Taché Y: Nesfatin-1: a novel inhibitory regulator of food intake and body weight. Obes Rev 2011; 12: 261-271.